BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10748100)

  • 21. p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1.
    Hu MC; Wasserman D; Hartwig S; Rosenblum ND
    J Biol Chem; 2004 Mar; 279(13):12051-9. PubMed ID: 14718543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth/differentiation factor-5 induces growth arrest and apoptosis in mouse B lineage cells with modulation by Smad.
    Nakahara T; Tominaga K; Koseki T; Yamamoto M; Yamato K; Fukuda J; Nishihara T
    Cell Signal; 2003 Feb; 15(2):181-7. PubMed ID: 12464389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells.
    Nakamura K; Shirai T; Morishita S; Uchida S; Saeki-Miura K; Makishima F
    Exp Cell Res; 1999 Aug; 250(2):351-63. PubMed ID: 10413589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser-727 phosphorylation.
    Kojima H; Sasaki T; Ishitani T; Iemura S; Zhao H; Kaneko S; Kunimoto H; Natsume T; Matsumoto K; Nakajima K
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4524-9. PubMed ID: 15764709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.
    Ungefroren H; Lenschow W; Chen WB; Faendrich F; Kalthoff H
    J Biol Chem; 2003 Mar; 278(13):11041-9. PubMed ID: 12538652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smad and p38-MAPK signaling mediates apoptotic effects of transforming growth factor-beta1 in human airway epithelial cells.
    Undevia NS; Dorscheid DR; Marroquin BA; Gugliotta WL; Tse R; White SR
    Am J Physiol Lung Cell Mol Physiol; 2004 Sep; 287(3):L515-24. PubMed ID: 15132952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells.
    Kim KY; Kim BC; Xu Z; Kim SJ
    J Biol Chem; 2004 Jul; 279(28):29478-84. PubMed ID: 15069087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction.
    Wang W; Zhou G; Hu MC; Yao Z; Tan TH
    J Biol Chem; 1997 Sep; 272(36):22771-5. PubMed ID: 9278437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling.
    Sano Y; Harada J; Tashiro S; Gotoh-Mandeville R; Maekawa T; Ishii S
    J Biol Chem; 1999 Mar; 274(13):8949-57. PubMed ID: 10085140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of transforming growth factor beta-activated kinase 1 (TAK1) on apoptosis of HK-2 cells in the high glucose environment.
    Wang Y; Zhao L; Qiu D; Shi Y; Duan H
    Bioengineered; 2022 Mar; 13(3):5880-5891. PubMed ID: 35184673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen.
    Kim SI; Kwak JH; Zachariah M; He Y; Wang L; Choi ME
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1471-8. PubMed ID: 17299140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways.
    Abécassis L; Rogier E; Vazquez A; Atfi A; Bourgeade MF
    J Biol Chem; 2004 Jul; 279(29):30474-9. PubMed ID: 15133024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAK1 participates in c-Jun N-terminal kinase signaling during Drosophila development.
    Takatsu Y; Nakamura M; Stapleton M; Danos MC; Matsumoto K; O'Connor MB; Shibuya H; Ueno N
    Mol Cell Biol; 2000 May; 20(9):3015-26. PubMed ID: 10757786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
    Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
    Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone morphogenetic protein signaling in articular chondrocyte differentiation.
    Nishihara A; Fujii M; Sampath TK; Miyazono K; Reddi AH
    Biochem Biophys Res Commun; 2003 Feb; 301(2):617-22. PubMed ID: 12565908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway.
    Rousse S; Lallemand F; Montarras D; Pinset C; Mazars A; Prunier C; Atfi A; Dubois C
    J Biol Chem; 2001 Dec; 276(50):46961-7. PubMed ID: 11598109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1).
    Kaur S; Wang F; Venkatraman M; Arsura M
    J Biol Chem; 2005 Nov; 280(46):38599-608. PubMed ID: 16157589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
    Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
    Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
    Lee KS; Hong SH; Bae SC
    Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
    Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
    J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.